|
US3048526A
(en)
|
1958-08-04 |
1962-08-07 |
Wander Company |
Medicinal tablet
|
|
GB972128A
(en)
|
1960-01-21 |
1964-10-07 |
Wellcome Found |
Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
|
|
US3125491A
(en)
|
1962-04-06 |
1964-03-17 |
|
Chew able hematinic vitamin tablet |
|
FR1603314A
(en)
|
1965-02-23 |
1971-04-05 |
|
Pharmaceutical tablets - having a core and a matrix material
|
|
US3870790A
(en)
|
1970-01-22 |
1975-03-11 |
Forest Laboratories |
Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
|
|
FR2100858B1
(pt)
|
1970-07-03 |
1975-06-06 |
Daiichi Seiyaku Co |
|
|
DE2445971A1
(de)
|
1974-09-24 |
1976-04-08 |
Schering Ag |
Arzneimittelwirkstofftraeger ii
|
|
US4797288A
(en)
|
1984-10-05 |
1989-01-10 |
Warner-Lambert Company |
Novel drug delivery system
|
|
GB8518301D0
(en)
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
|
US5519057A
(en)
|
1986-11-14 |
1996-05-21 |
Johnson & Johnson--Merck Pharmaceuticals Co. |
Ibuprofen-containing medicament
|
|
IT1201136B
(it)
|
1987-01-13 |
1989-01-27 |
Resa Farma |
Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
|
|
GB8705083D0
(en)
|
1987-03-04 |
1987-04-08 |
Euro Celtique Sa |
Spheroids
|
|
GB8820353D0
(en)
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
|
US5047246A
(en)
|
1988-09-09 |
1991-09-10 |
Bristol-Myers Company |
Direct compression cyclophosphamide tablet
|
|
IT1230576B
(it)
|
1988-10-20 |
1991-10-28 |
Angeli Inst Spa |
Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
|
|
US4966770A
(en)
|
1989-07-26 |
1990-10-30 |
Himedics, Inc. |
Prednisone microencapsulated granules
|
|
DE3930770A1
(de)
|
1989-09-14 |
1991-03-28 |
Wolfgang F Dr Schoener |
Implantierbare katheter aus medizinisch vertraeglichem elastischen kunststoff
|
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
|
JP2558396B2
(ja)
|
1990-06-28 |
1996-11-27 |
田辺製薬株式会社 |
放出制御型製剤
|
|
JP2521848B2
(ja)
|
1990-07-02 |
1996-08-07 |
ベーリンガー マンハイム ゲーエムベーハー |
成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
|
|
ATE105710T1
(de)
|
1990-07-02 |
1994-06-15 |
Boehringer Mannheim Gmbh |
Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
|
|
IE61651B1
(en)
|
1990-07-04 |
1994-11-16 |
Zambon Spa |
Programmed release oral solid pharmaceutical dosage form
|
|
US5310578A
(en)
|
1990-09-17 |
1994-05-10 |
Merck Patent Gesellschaft |
Deposition of cosmetically functional material onto pigments and fillers
|
|
US5316772A
(en)
|
1990-12-19 |
1994-05-31 |
Solvay & Cie, S.A. (Societe Anonyme) |
Bilayered oral pharmaceutical composition with pH dependent release
|
|
CA2100272A1
(en)
|
1991-01-03 |
1992-07-04 |
Thomas Patrick Molloy |
Method for production of solid pharmaceutical preparation
|
|
DE4100920A1
(de)
*
|
1991-01-15 |
1992-07-16 |
Degussa |
Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
|
|
DE69222006T2
(de)
|
1991-10-30 |
1998-01-22 |
Glaxo Group Ltd |
Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
|
|
AU3949093A
(en)
|
1992-03-31 |
1993-11-08 |
Benzon Pharma A/S |
A pharmaceutical formulation
|
|
GB9215908D0
(en)
|
1992-07-27 |
1992-09-09 |
Wellcome Found |
Water dispersible tablets
|
|
JPH07507564A
(ja)
|
1992-09-30 |
1995-08-24 |
ファイザー・インク． |
コア及び厚さが一定でないコーティングを含有する物品
|
|
WO1994008589A1
(en)
|
1992-10-09 |
1994-04-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of systemic lupus erythematosus with dehydroepiandrosterone
|
|
TW272942B
(pt)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
|
DK66493D0
(da)
|
1993-06-08 |
1993-06-08 |
Ferring A S |
Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
|
|
IL110376A
(en)
|
1993-08-02 |
1998-08-16 |
Bristol Myers Squibb Co |
Pharmaceutical preparations containing iftroban and methods for their preparation
|
|
DE4332394A1
(de)
|
1993-09-23 |
1995-03-30 |
Falk Pharma Gmbh |
Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
|
|
US5482718A
(en)
|
1994-03-23 |
1996-01-09 |
Hoffmann-La Roche Inc. |
Colon-targeted delivery system
|
|
US5464633A
(en)
|
1994-05-24 |
1995-11-07 |
Jagotec Ag |
Pharmaceutical tablets releasing the active substance after a definite period of time
|
|
US5702723A
(en)
|
1994-08-02 |
1997-12-30 |
Griffin; David |
Multi-stage delivery system for ingestible medications or nutrients
|
|
US5811388A
(en)
|
1995-06-07 |
1998-09-22 |
Cibus Pharmaceutical, Inc. |
Delivery of drugs to the lower GI tract
|
|
US5709880A
(en)
|
1995-07-10 |
1998-01-20 |
Buckman Laboratories International, Inc. |
Method of making tabletized ionene polymers
|
|
IT1276031B1
(it)
|
1995-10-31 |
1997-10-24 |
Angelini Ricerche Spa |
Composizione farmaceutica per il trattamento delle malattie autoimmuni
|
|
JP3220373B2
(ja)
|
1995-11-28 |
2001-10-22 |
バイエル薬品株式会社 |
持続性ニフエジピン製剤
|
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5840332A
(en)
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
|
AU1751997A
(en)
|
1996-01-30 |
1997-08-22 |
Advanced Polymer Systems Inc. |
Targeted delivery of drugs to the lower gastrointestinal tract
|
|
IT1282576B1
(it)
|
1996-02-06 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
|
|
HRP970493A2
(en)
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
|
ATE277739T1
(de)
|
1996-10-28 |
2004-10-15 |
Gen Mills Inc |
Einbettung und einkapselung von teilchen zur kontrollierten abgabe
|
|
US5792476A
(en)
*
|
1996-12-19 |
1998-08-11 |
Abigo Medical Ab |
Sustained release glucocorticoid pharmaceutical composition
|
|
US5788987A
(en)
*
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
CN1256085C
(zh)
|
1997-07-01 |
2006-05-17 |
美国辉瑞有限公司 |
舍曲林盐和舍曲林的缓释剂型
|
|
US6013280A
(en)
|
1997-10-07 |
2000-01-11 |
Fuisz Technologies Ltd. |
Immediate release dosage forms containing microspheres
|
|
WO1999018938A1
(en)
|
1997-10-09 |
1999-04-22 |
Perio Products Ltd. |
Delayed total release gastrointestinal drug delivery system
|
|
US7201923B1
(en)
|
1998-03-23 |
2007-04-10 |
General Mills, Inc. |
Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
|
|
US6365185B1
(en)
*
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
ATE267589T1
(de)
|
1998-04-03 |
2004-06-15 |
Egalet As |
Zusammensetzung mit kontrollierter wirkstoff- freisetzung
|
|
US6602521B1
(en)
|
1998-09-29 |
2003-08-05 |
Impax Pharmaceuticals, Inc. |
Multiplex drug delivery system suitable for oral administration
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
ATE433318T1
(de)
|
1999-02-10 |
2009-06-15 |
Pfizer Prod Inc |
Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
GB9905898D0
(en)
|
1999-03-15 |
1999-05-05 |
Darwin Discovery Ltd |
Controlled-dose formulation
|
|
US6677326B2
(en)
|
1999-03-15 |
2004-01-13 |
Arakis, Ltd. |
Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
|
|
US6245352B1
(en)
|
1999-04-27 |
2001-06-12 |
Eli Lilly And Company |
Pharmaceutical formulation
|
|
JP2001010950A
(ja)
|
1999-06-29 |
2001-01-16 |
Taiyo Yakuhin Kogyo Kk |
安定で良好な薬物放出を有する医薬組成物
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
EP1074249A1
(en)
|
1999-07-27 |
2001-02-07 |
Jagotec Ag |
A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to a no-release period
|
|
US6428809B1
(en)
|
1999-08-18 |
2002-08-06 |
Microdose Technologies, Inc. |
Metering and packaging of controlled release medication
|
|
AR026148A1
(es)
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
|
DE10012555A1
(de)
|
2000-03-15 |
2001-09-20 |
Merck Patent Gmbh |
Glucocorticoide in einer Modified Release-Formulierung
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
US20020028240A1
(en)
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
|
AU2001247887A1
(en)
|
2000-04-19 |
2001-11-07 |
Eurand America Inc. |
Dual mechanism timed release dosage forms for low dose drugs
|
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
|
US6476006B2
(en)
|
2000-06-23 |
2002-11-05 |
Teva Pharmaceutical Industries, Ltd. |
Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
|
|
US6720005B1
(en)
|
2000-07-07 |
2004-04-13 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Coated, platform-generating tablet
|
|
US6620439B1
(en)
|
2000-10-03 |
2003-09-16 |
Atul M. Mehta |
Chrono delivery formulations and method of use thereof
|
|
US6589562B1
(en)
|
2000-10-25 |
2003-07-08 |
Salvona L.L.C. |
Multicomponent biodegradable bioadhesive controlled release system for oral care products
|
|
US6887493B2
(en)
|
2000-10-25 |
2005-05-03 |
Adi Shefer |
Multi component controlled release system for oral care, food products, nutraceutical, and beverages
|
|
US6565873B1
(en)
|
2000-10-25 |
2003-05-20 |
Salvona Llc |
Biodegradable bioadhesive controlled release system of nano-particles for oral care products
|
|
AU2002244295B2
(en)
|
2001-03-13 |
2006-02-09 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms containing glucocorticosteroid
|
|
DE60237363D1
(de)
|
2001-03-15 |
2010-09-30 |
Soligenix Inc |
Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
|
|
IN191028B
(pt)
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US20030021841A1
(en)
|
2001-07-02 |
2003-01-30 |
Matharu Amol Singh |
Pharmaceutical composition
|
|
EP2238975B1
(en)
|
2001-07-04 |
2012-12-05 |
Sun Pharma Advanced Research Company Ltd |
Gastric retention controlled drug delivery system
|
|
US7163700B2
(en)
|
2001-07-31 |
2007-01-16 |
Capricorn Pharma, Inc. |
Amorphous drug beads
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
|
BR0212951A
(pt)
|
2001-09-28 |
2004-10-26 |
Mcneil Ppc Inc |
Formas de dosagens compósitas
|
|
AU2002334939A1
(en)
|
2001-10-12 |
2003-04-22 |
Eugene R. Cooper |
Compositions having a combination of particles for immediate release and for controlled release
|
|
US20080145438A1
(en)
|
2001-12-20 |
2008-06-19 |
Beuford Arlie Bogue |
Micro- and nano-particulate drugs and methods of making thereof
|
|
US20030203030A1
(en)
|
2002-01-18 |
2003-10-30 |
Control Delivery Systems, Inc. |
Polymeric gel delivery system for pharmaceuticals
|
|
AU2003208761A1
(en)
|
2002-02-21 |
2003-09-09 |
Amarin Development Ab |
A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use
|
|
WO2003075919A1
(fr)
|
2002-03-14 |
2003-09-18 |
Daiichi Suntory Pharma Co.,Ltd. |
Comprime contenant du chlorhydrate de pilsicainide (voie seche)
|
|
CA2479665C
(en)
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US20040062778A1
(en)
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
|
ES2355233T3
(es)
|
2002-09-28 |
2011-03-24 |
Mcneil-Ppc, Inc. |
Formas de dosificación de liberación modificada con dos núcleos y una abertura.
|
|
US20080220074A1
(en)
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
|
US7704527B2
(en)
|
2002-10-25 |
2010-04-27 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
|
EP1585502B9
(en)
|
2002-11-12 |
2012-05-09 |
Elan Pharma International Limited |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
ATE445393T1
(de)
|
2003-04-24 |
2009-10-15 |
Jagotec Ag |
Tablette mit gefärbtem kern
|
|
BRPI0409652A
(pt)
|
2003-04-24 |
2006-04-25 |
Jagotec Ag |
tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete
|
|
US20060177507A1
(en)
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
|
US8029822B2
(en)
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
|
UY28326A1
(es)
|
2003-05-22 |
2004-06-30 |
Osmotica Argentina S A |
Dispositivo de ruptura de liberacion controlada con un pasaje preformado
|
|
JP2007001865A
(ja)
|
2003-09-16 |
2007-01-11 |
Ltt Bio-Pharma Co Ltd |
脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
|
|
EP1663156A2
(en)
|
2003-09-19 |
2006-06-07 |
Penwest Pharmaceuticals Company |
Chronotherapeutic dosage forms
|
|
DE102004035936A1
(de)
|
2004-07-23 |
2006-03-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
|
CA2579732C
(en)
*
|
2004-09-10 |
2014-08-12 |
Nitec Pharma Ag |
Tablets with site time-controlled gastrointestinal release of active ingredient
|
|
DE102004043863A1
(de)
|
2004-09-10 |
2006-03-16 |
Nitec Pharma Ag |
Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
|
|
GB0427455D0
(en)
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
|
WO2006099445A2
(en)
|
2005-03-14 |
2006-09-21 |
Massachusetts Institute Of Technology |
Nanocells for diagnosis and treatment of diseases and disorders
|
|
US9149439B2
(en)
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
|
WO2007002597A2
(en)
|
2005-06-27 |
2007-01-04 |
Biovail Laboratories International S.R.L. |
Modified-release formulations of a bupropion salt
|
|
WO2007036952A2
(en)
|
2005-07-01 |
2007-04-05 |
Rubicon Research Pvt Ltd. |
Novel sustained release dosage form
|
|
US20080248107A1
(en)
|
2005-08-24 |
2008-10-09 |
Rubicon Research Pvt. Ltd. |
Controlled Release Formulation
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
US9125833B2
(en)
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US20120121653A1
(en)
|
2005-12-02 |
2012-05-17 |
Elan Pharma International Limited |
Novel mometasone compositions and methods of making and using the same
|
|
US20080213374A1
(en)
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
|
US20080014272A1
(en)
|
2006-07-11 |
2008-01-17 |
Phil Skolnick |
Compositions and Methods for Treatment of Chronic Pain Conditions
|
|
US20080026040A1
(en)
|
2006-07-31 |
2008-01-31 |
Isaac Farr |
Active agent-releasing dosage forms
|
|
UA96457C2
(ru)
|
2006-08-03 |
2011-11-10 |
Нитек Фарма Аг |
Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением
|
|
WO2008016729A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
|
CL2007002214A1
(es)
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
|
MX2009002236A
(es)
|
2006-08-30 |
2009-03-13 |
Jagotec Ag |
Formulaciones de dosis oral de liberacion controlada que comrpenden un nucleo y una o mas capas de barrera.
|
|
US20080057086A1
(en)
|
2006-09-01 |
2008-03-06 |
Pharmion Corporation |
Colon-targeted oral formulations of cytidine analogs
|
|
US20080166303A1
(en)
|
2006-09-08 |
2008-07-10 |
Dov Tamarkin |
Colored or colorable foamable composition and foam
|
|
WO2008033351A2
(en)
|
2006-09-11 |
2008-03-20 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant and extended release formulations
|
|
EP2097086A4
(en)
|
2006-11-14 |
2012-01-11 |
Yissum Res Dev Co |
CONTACT LENS COMPOSITIONS
|
|
WO2008079963A2
(en)
|
2006-12-22 |
2008-07-03 |
Cambrex Charles City, Inc. |
Pharmaceutical compositions comprising ionic complexes of active pharmaceutical ingredients
|
|
WO2008085484A2
(en)
|
2006-12-28 |
2008-07-17 |
Jacobus Pharmaceutical Company, Inc. |
Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
|
|
GB2445539A
(en)
|
2006-12-29 |
2008-07-16 |
Ardana Bioscience Ltd |
Bigel composition
|
|
WO2008094877A2
(en)
|
2007-01-30 |
2008-08-07 |
Drugtech Corporation |
Compositions for oral delivery of pharmaceuticals
|
|
US20100016322A1
(en)
|
2007-02-28 |
2010-01-21 |
Nagesh Nagaraju |
Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
|
|
EP2146690B1
(en)
|
2007-04-13 |
2018-03-21 |
Teva Pharmaceuticals International GmbH |
Oral cephalotaxine dosage forms
|
|
JP5612462B2
(ja)
|
2007-04-13 |
2014-10-22 |
ダウ グローバル テクノロジーズ エルエルシー |
剤形用の粒状物質
|
|
WO2008140459A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
|
WO2008140460A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
|
US20080311162A1
(en)
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
|
US20080286343A1
(en)
|
2007-05-16 |
2008-11-20 |
Dzenana Cengic |
Solid form
|
|
EP2167033B1
(en)
|
2007-05-30 |
2017-04-19 |
Veloxis Pharmaceuticals A/S |
Once daily oral dosage form comprising tacrolimus
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
EP2008651A1
(en)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
A bioerodible patch
|
|
EP2187872A4
(en)
|
2007-08-13 |
2013-09-18 |
Panacea Biotec Ltd |
EXTENDED RELEASE COMPOSITIONS COMPRISING SODIUM MYCOPHENOLATE AND METHODS RELATING THERETO
|
|
SI2200588T1
(sl)
|
2007-09-25 |
2019-08-30 |
Solubest Ltd. |
Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo
|
|
US20110091566A1
(en)
|
2007-09-25 |
2011-04-21 |
Nirmal Mulye |
Controlled release pharmaceutical compositions
|
|
AR068745A1
(es)
|
2007-10-08 |
2009-12-02 |
Panacea Biotec Ltd |
Una composicion en forma de dosificacion farmaceutica oral de unidad de alta dosis de micofenolato sodico, metodo para utilizar dicha composicion y sus usos
|
|
JP2011500553A
(ja)
|
2007-10-10 |
2011-01-06 |
ルピン・リミテッド |
５−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤
|
|
US8865692B2
(en)
|
2007-11-13 |
2014-10-21 |
Meritage Pharma, Inc |
Compositions for the treatment of gastrointestinal inflammation
|
|
JP2011507861A
(ja)
|
2007-12-21 |
2011-03-10 |
コーダ セラピューティクス， インコーポレイテッド |
線維症性の状態の治療のための抗コネキシンポリヌクレオチド剤と組み合わせた抗コネキシンポリペプチド剤の使用
|
|
EP2252320A2
(en)
|
2007-12-21 |
2010-11-24 |
Coda Therapeutics, Inc. |
Use of anti-connexin polynucleotides and peptides for the treatment of abnormal or excessive scars
|
|
US20110243964A1
(en)
|
2007-12-21 |
2011-10-06 |
Bradford James Duft |
Treatment of orthopedic conditions
|
|
MX2010009704A
(es)
|
2008-03-05 |
2010-12-20 |
Panacea Biotec Ltd |
Composiciones farmaceuticas de liberacion modifcada que comprenden micofenolato y procesos de estas.
|
|
WO2009142772A2
(en)
|
2008-05-23 |
2009-11-26 |
Mastcell Pharmaceuticals, Inc. |
Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
|
|
US8648119B2
(en)
|
2008-05-23 |
2014-02-11 |
Otonomy, Inc. |
Controlled release immunomodulator compositions and methods for the treatment of otic disorders
|
|
WO2010005687A1
(en)
|
2008-06-12 |
2010-01-14 |
University Of Alabama Huntsville |
Compositions comprising nitric oxide or nitric oxide donors for the treatment of neurodegenerative diseases or trauma
|
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
CA2749646A1
(en)
|
2009-01-26 |
2010-07-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of asthma
|
|
NZ582836A
(en)
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|